11 Dec SurgiLance™ Safety Lancets Now Registered with French Needlestick Safety Agency
PARIS, Dec. 11 — MediPurpose, a medical device innovation and medical product distribution company, announced today that its SurgiLance Safety Lancet has been validated by the Safety Medical Device Commission of GERES, the French advocacy organization for needlestick safety.
With the recent approval, SurgiLance Safety Lancet will be featured on the GERES Website under the heading “Guide des Materiels de Protection.” GERES provides a list of approved safety products for medical staff, helping to assure the safety of healthcare providers.
The SurgiLance Safety Lancet is pre-armed and color-coded for easy recognition. Additionally, the lancet needle or blade is safely concealed, both before and after use.
Known for meeting and exceeding superior medical safety standards, MediPurpose has long been associated with U.S. and other international needlestick prevention groups such as ISIPS, the International Sharps Injury Protection Society.
“This recognition by GERES in France is a validation of our success in providing innovative healthcare solutions with an unwavering commitment to safety,” said Stella Avarre, MediPurpose sales and marketing manager in France. “Safety lies at the heart of all that we do at MediPurpose.”
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and the United Kingdom.
Known for its innovation of the SurgiLance Safety Lancet, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor.
MediPurpose also offers angel funding, medical product development and medical device consulting for medical device inventors and medical product companies seeking entrance or expansion into the medical device markets.
For more information about MediPurpose’s medical products, medical distribution channel management services and medical product development services, please visit www.medipurpose.com.